Área de investigación Biología y Biomedicina Instituto INSTITUTO DE PARASITOLOGIA Y BIOMEDICINA LOPEZ NEYRA Importe 207.764,80 € Development of FLDK-1 a potent and selective first-in-class drug for the treatment of Inflammatory Bowel Disease (IBD) Integrantes: